Prot#AG-CLTI-0211: A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects who have Peripheral Ischemic Ulcers of the Lower Extremity